الفهرس 
Psoriasis; What We Should Know?Only 14 pages are availabe for public view
 |  | from | 143 |  |  |
| | | from | 143 | | |
Abstract
Psoriasis is a chronic, non-communicable, painful, disfiguring and disabling disease with great negative impact on patients’ quality of life (QoL). It can occur at any age, and is most common in the age group 50–69. The reported prevalence of psoriasis in countries ranges between 0.09% and 11.4%, making psoriasis a serious global problem.
The aim of the study is to identify the prevalence of psoriasis in Cairo governorate, the associated socio-demographic and anthropometric data, and percentage of each clinical type, as well as to define the possible precipitating factors and other diseases related to psoriasis.
This cross-sectional observational study included patients with psoriasis collected from patients attending the outpatient Dermatology and Andrology Department of Educational Hospitals of Cairo Governorate (Al Haud AlMarsoud Hospital & Ain Shams University Hospital) during a period of six months that started from June 2020 to December 2020. It was a multi-center study including 2 Educational Dermatology hospitals. This study was approved by the research ethical committee of Ain Shams University & fulfilled all the ethical aspects required in human research.
The overall number of patients visiting those hospitals in the period of the study was 41155 patients. Of these, 150 patients had psoriasis, so the prevalence of psoriasis was 0.36%.
We found significant association between severity of psoriasis with male gender, with degree of impairment of life, with skin type III, and with higher age of onset.
We observed no association of psoriasis severity with DM, hypertension, BMI, or joint manifestations. Our findings are similar to most of other published epidemiological studies on psoriasis.